Explain the mechanism of acute respiratory distress syndrome

Reading File

Finding Sources

Searching PubMed

"acute respiratory distress syndrome"[MeSH Terms] AND pathophysiology

Reading File

Loading Image

I now have all the material needed for a thorough, well-sourced answer. Here is a full explanation of ARDS mechanism:

Acute Respiratory Distress Syndrome (ARDS): Mechanism

Definition and Diagnostic Criteria (Berlin Definition)

ARDS is an inflammatory lung injury characterized by bilateral infiltrates on chest radiograph or CT, a PaO2/FiO2 (P/F) ratio <300 mmHg on at least 5 cm H2O PEEP, onset within 7 days of a recognized insult, and pulmonary edema not fully explained by cardiac failure or fluid overload. Severity is stratified as mild (P/F 200-300), moderate (P/F 100-200), and severe (P/F <100).

Sabiston Textbook of Surgery, p. 940

Inciting Events: Direct vs. Indirect Injury

Risk factors divide into two broad categories:

Direct (Pulmonary) Injury	Indirect (Nonpulmonary) Injury
Pneumonia (bacterial, viral, COVID-19)	Sepsis
Aspiration of gastric contents	Major trauma
Pulmonary contusion	Multiple blood transfusions
Toxic inhalation / near-drowning	Pancreatitis
Reperfusion injury (post-lung transplant)	Cardiopulmonary bypass, drug overdose

Sepsis carries the highest risk (up to 43% of cases develop ARDS). The presence of multiple risk factors compounds the likelihood significantly.

Murray & Nadel's Textbook of Respiratory Medicine, p. 3145

Core Pathophysiology: Breakdown of the Alveolar-Capillary Barrier

The central event in ARDS is increased permeability of the alveolar-capillary membrane, distinguishing it from cardiogenic (hydrostatic) pulmonary edema. The alveoli fill with protein-rich, exudative fluid rather than transudate. This triggers a cascade:

Alveolar flooding reduces functional residual capacity (FRC)
Right-to-left shunting and low V/Q regions cause profound hypoxemia refractory to supplemental O2
Dead space ventilation increases significantly (alveoli are ventilated but not perfused)
Lung compliance falls, requiring higher airway pressures to deliver tidal volumes
Pulmonary hypertension develops via hypoxic vasoconstriction, intravascular fibrin deposition, and compression of vessels by positive-pressure ventilation

Murray & Nadel's Textbook of Respiratory Medicine, p. 3144-3145

Pathological Phases: Diffuse Alveolar Damage (DAD)

ARDS progresses through three overlapping stages:

1. Exudative Phase (Days 1-7)

Hyaline membranes form (composed of cellular debris, plasma proteins, and surfactant components)
Protein-rich fluid floods alveolar spaces
Widespread epithelial disruption (particularly Type I pneumocytes)
Heavy neutrophil infiltration of interstitium and airspaces

2. Proliferative Phase (Days 7-14)

Hyaline membranes undergo organization
Early fibrosis appears
Pulmonary capillary obliteration begins
Interstitial and alveolar collagen deposition
Neutrophil numbers decline; Type II pneumocyte proliferation attempts repair

3. Fibrotic Phase (>14 days, in a subset)

Established pulmonary fibrosis
Notably, elevated N-terminal procollagen peptide III (a marker of collagen synthesis) can be detected in BAL fluid as early as 24 hours after onset - suggesting fibroproliferation begins simultaneously with acute inflammation, not after it
Murray & Nadel's Textbook of Respiratory Medicine, p. 3144-3145

Cellular and Molecular Mechanisms

Alveolar Epithelial Injury (Key Initiating Event)

Damage to the alveolar epithelium - especially Type I pneumocytes (covering ~95% of the alveolar surface) - is considered the pivotal precipitating event. Multiple mechanisms drive epithelial cell death:

Direct cytotoxicity from pathogens or toxins
Neutrophil-derived oxidants and proteases
Fas/FasL-mediated apoptosis
Endoplasmic reticulum stress

Loss of Type I cells impairs the epithelial barrier, allowing protein-rich fluid to pour into the airspace. Loss of Type II pneumocytes reduces surfactant production, worsening alveolar collapse and increasing surface tension.

Neutrophil-Mediated Injury

Activated neutrophils are the central effector cells. Sequestration of neutrophils within alveolar and interstitial spaces is driven by:

TNF-alpha and IL-8 (released from macrophages and epithelial cells)
Complement activation (C5a)
Platelet-activating factor (PAF)

Once activated, neutrophils release:

Proteases (elastase, matrix metalloproteinases) - degrade the extracellular matrix and epithelial tight junctions
Reactive oxygen species (ROS) - oxidize lipid membranes and proteins, further disrupting barrier integrity
Leukotrienes and prostaglandins - amplify local inflammation and increase vascular permeability

Mechanisms of lung injury in ARDS showing macrophages (mφ), neutrophils, and bacteria releasing cytokines, complement, prostaglandins (PGs), leukotrienes (LTs), ROS, and proteases that damage the epithelium/interstitium and increase alveolar-capillary permeability

Microvascular Endothelial Injury

The pulmonary microvascular endothelium is simultaneously damaged:

Cytokines cause endothelial cell retraction and gap formation
Loss of endothelial barrier allows plasma proteins and fluid to leak into the interstitium and airspaces
Endothelial activation upregulates adhesion molecules (ICAM-1, E-selectin), recruiting more neutrophils

Inflammation-Coagulation Crosstalk

Inflammation and coagulation are deeply interconnected in ARDS:

TNF-alpha increases thrombin/fibrin formation, stimulates tissue factor expression on endothelial cells, and inhibits fibrinolysis
Fibrin fragments are chemotactic for neutrophils, amplifying the inflammatory loop
Intravascular fibrin deposition occludes pulmonary microvessels, contributing to pulmonary hypertension and dead space
Endogenous activated protein C (an anticoagulant) has anti-inflammatory effects including downregulating IL-6 and attenuating neutrophil activation; its function is impaired in ARDS
Murray & Nadel's Textbook of Respiratory Medicine, p. 3163-3164

Surfactant Dysfunction

Surfactant is both depleted (Type II pneumocyte loss) and inactivated (by plasma proteins leaking into alveoli). In pancreatitis-associated ARDS, phospholipase A2 directly degrades surfactant enzymatically. Loss of surfactant increases alveolar surface tension, causing diffuse microatelectasis and further worsening shunt.

Murray & Nadel's Textbook of Respiratory Medicine, p. 2961

Impaired Alveolar Fluid Clearance

Normal alveolar fluid reabsorption depends on apical Na+ channels (ENaC) on Type II pneumocytes and basolateral Na+/K+ ATPases. In ARDS:

Hypoxia downregulates ENaC expression and activity
Hypoxia inhibits Na+/K+ ATPase activity
Increased nitric oxide in the lung impairs the catecholamine-driven upregulation of fluid reabsorption
The net result is flooded alveoli that cannot clear edema fluid effectively
Murray & Nadel's Textbook of Respiratory Medicine, p. 3201-3203

Ventilator-Induced Lung Injury (VILI): Amplifying the Damage

Mechanical ventilation, while life-saving, can worsen ARDS through two mechanisms:

Biophysical injury:

Volutrauma/barotrauma: Overdistention of relatively normal alveoli adjacent to collapsed regions
Atelectrauma: Cyclic opening and closing (shear stress) of unstable alveolar units

Biochemical injury (biotrauma):

Injurious ventilation promotes release of cytokines, complement, ROS, and proteases from macrophages and neutrophils within the lung
These mediators spill into the systemic circulation and can contribute to multi-organ failure

This is why lung-protective ventilation (tidal volumes 6-8 mL/kg predicted body weight, plateau pressure ≤30 cm H2O) is the cornerstone of ARDS management.

Goldman-Cecil Medicine, p. 1066-1067

Summary: The Unified Mechanism

Inciting Insult (sepsis, pneumonia, aspiration, trauma, etc.)
        ↓
Macrophage/epithelial cell activation
        ↓
Release of TNF-α, IL-1β, IL-8, complement, PAF
        ↓
Neutrophil sequestration in alveolar-capillary bed
        ↓
Neutrophil release of ROS, proteases, leukotrienes
        ↓
Alveolar epithelial + microvascular endothelial injury
        ↓
Increased alveolar-capillary permeability
        ↓
Protein-rich exudate floods alveoli
        ↓
Surfactant dysfunction + impaired Na+ fluid clearance
        ↓
Alveolar collapse, V/Q mismatch, shunt → hypoxemia
        ↓
↓ Compliance, ↑ dead space, pulmonary hypertension
        ↓
Diffuse Alveolar Damage (DAD) + risk of fibroproliferation

Mechanical ventilation can perpetuate the cycle through biotrauma, releasing inflammatory mediators that worsen both lung injury and distal organ dysfunction.

Key sources:

Murray & Nadel's Textbook of Respiratory Medicine (2-Volume)
Goldman-Cecil Medicine
Sabiston Textbook of Surgery

This is a shared conversation. Sign in to Orris to start your own chat.